Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair

Advances in Cancer Research

Volumn 91, Issue , 2004, Pages 69-136

  Finch, Paul W ^a   Rubin, Jeffrey S ^b  

^a Croton on Hudson   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; RECEPTOR SUBUNIT; RECOMBINANT PROTEIN;

BLADDER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL ACTIVATION; CELL ACTIVITY; CELL DAMAGE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL REGENERATION; CELL STIMULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CLINICAL TRIAL; DNA REPAIR; DRUG MECHANISM; DRUG POTENCY; ENZYME INDUCTION; EPITHELIOID CELL; EXPERIMENTAL MODEL; GASTROINTESTINAL TRACT; GENE STRUCTURE; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG; MITOGENICITY; MOLECULAR BIOLOGY; MOUTH MUCOSA; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKIN; SOLID TUMOR; TISSUE INJURY; TISSUE REPAIR;

EID: 4344609471     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(04)91003-2     Document Type: Article

References (333)

1. Adamson I.Y., Bakowska J. Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin. Am. J. Pathol. 155:1999;949-954
2. Ago H., Kitagawa Y., Fujishima A., Matsuura Y., Katsube Y. Crystal structure of basic fibroblast growth factor at 1.6 Å resolution. J. Biochem. (Tokyo). 110:1991;360-363
3. Alarid E.T., Rubin J.S., Young P., Chedid M., Ron D., Aaronson S.A., Cunha G.R. Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc. Natl. Acad. Sci. USA. 91:1994;1074-1078
4. Allen B.L., Rapraeger A.C. Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J. Cell Biol. 163:2003;637-648
5. Andreadis S.T., Hamoen K.E., Yarmush M.L., Morgan J.R. Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 15:2001;898-906
6. Atabai K., Ishigaki M., Geiser T., Ueki I., Matthay M.A., Ware L.B. Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms. Am. J. Physiol. Lung Cell Mol. Physiol. 283:2002;L163-L169
7. Aviezer D., Levy E., Safran M., Svahn C., Buddecke E., Schmidt A., David G., Vlodavsky I., Yayon A. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem. 269:1994;114-121
8. Bajaj-Elliott M., Breese E., Poulsom R., Fairclough P.D., MacDonald T.T. Keratinocyte growth factor in inflammatory bowel disease: Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts. Am. J. Pathol. 151:1997;1469-1476
9. Bansal G.S., Cox H.C., Marsh S., Gomm J.J., Yiangou C., Luqmani Y., Coombes R.C., Johnston C.L. Expression of keratinocyte growth factor and its receptor in human breast cancer. Br. J. Cancer. 75:1997;1567-1574
10. Barazzone C., Donati Y.R., Rochat A.F., Vesin C., Kan C.D., Pache J.C., Piguet P.F. Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am. J. Pathol. 154:1999;1479-1487
11. Baskin L.S., Sutherland R.S., Thomson A.A., Nguyen H.T., Morgan D.M., Hayward S.W., Hom Y.K., DiSandro M., Cunha G.R. Growth factors in bladder wound healing. J. Urol. 157:1997;2388-2395
12. Beer H.D., Florence C., Dammeier J., McGuire L., Werner S., Duan D.R. Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression. Oncogene. 15:1997;2211-2218
13. Beer H.D., Vindevoghel L., Gait M.J., Revest J.M., Duan D.R., Mason I., Dickson C., Werner S. Fibroblast growth factor (FGF) receptor 1-IIIb is a naturally occurring functional receptor for FGFs that is preferentially expressed in the skin and the brain. J. Biol. Chem. 275:2000;16091-16097
14. Beer H.D., Munding C., Dubois N., Mamie C., Hohl D., Werner S. The estrogen-responsive B box protein: A novel regulator of keratinocyte differentiation. J. Biol. Chem. 277:2002;20740-20749
15. Bellusci S., Grindley J., Emoto H., Itoh N., Hogan B.L. Fibroblast growth factor 10 (FGF-10) and branching morphogenesis in the embryonic mouse lung. Development. 124:1997;4867-4878
16. Berman B., Ostrovsky O., Shlissel M., Lang T., Regan D., Vlodavsky I., Ishai-Michaeli R., Ron D. Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor. J. Biol. Chem. 274:1999;36132-36138
17. Beyer T.A., Werner S., Dickson C., Grose R. Fibroblast growth factor 22 and its potential role during skin development and repair. Exp. Cell Res. 287:2003;228-236
18. Blaber M., DiSalvo J., Thomas K.A. X-ray crystal structure of human acidic fibroblast growth factor. Biochemistry. 35:1996;2086-2094
19. Boismenu R., Havran W.L. Modulation of epithelial cell growth by intraepithelial γδ T cells. Science. 266:1994;1253-1255
20. Bonneh-Barkay D., Shlissel M., Berman B., Shaoul E., Admon A., Vlodavsky I., Carey D.J., Asundi V.K., Reich-Slotky R., Ron D. Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J. Biol. Chem. 272:1997;12415-12421
21. Booth C., Potten C.S. Keratinocyte growth factor increases hair follicle survival following cytotoxic insult. J. Invest. Dermatol. 114:2000;667-673
22. +-ATPase expression in alveolar epithelial cells: Upregulation of active ion transport by KGF. Am. J. Physiol. 274:1998a;L149-L158
23. Borok Z., Lubman R.L., Danto S.I., Zhang X.L., Zabski S.M., King L.S., Lee D.M., Agre P., Crandall E.D. Keratinocyte growth factor modulates alveolar epithelial cell phenotype in vitro: Expression of aquaporin 5. Am. J. Respir. Cell Mol. Biol. 18:1998b;554-561
24. Bottaro D.P., Rubin J.S., Ron D., Finch P.W., Florio C., Aaronson S.A. Characterization of the receptor for keratinocyte growth factor: Evidence for multiple fibroblast growth factor receptors. J. Biol. Chem. 265:1990;12767-12770
25. Bottaro D.P., Fortney E., Rubin J.S., Aaronson S.A. A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site. J. Biol. Chem. 268:1993;9180-9183
26. Brauchle M., Angermeyer K., Hubner G., Werner S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene. 9:1994;3199-3204
27. Brauchle M., Fassler R., Werner S. Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing. J. Invest. Dermatol. 105:1995;579-584
28. Brauchle M., Madlener M., Wagner A.D., Angermeyer K., Lauer U., Hofschneider P.H., Gregor M., Werner S. Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am. J. Pathol. 149:1996;521-529
29. Braun S., Hanselmann C., Gassmann M.G., auf dem Keller U., Born-Berclaz C., Chan K., Kan Y.W., Werner S. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell. Biol. 22:2002;5492-5505
30. Brizel D.M., Herman T., Goffinet D., Sailer S., Agarwala S., Schwartz G., Venkatesan V., Cripps C., Meredith R.F., Logan E., Yao B. A phase III trial of escalating doses of recombinant human keratinocyte growth factor (rHuKGF) in head and neck cancer (HNC) patients receiving radiotherapy (RT) with concurrent chemotherapy (CCT) [abstract 67]. Int. J. Radiat. Oncol. Biol. Phys. 51:(Suppl. 1):2001;40
31. Brizel D.M., Le Q.T., Rosenthal D., Meredith R., Brizel H.E., Heard R., Yao B., Eng T., Sailer S., Chen Y., Murphy B., Mendenhall W. Phase 2 study of recombinant human keratinocyte growth factor (rHuKGF) in head and neck cancer treated with standard (SRT) or hyperfractionated irradiation (HRT) and concurrent chemotherapy (CT) [abstract 2128]. Int. J. Radiat. Oncol. Biol. Phys. 54:(Suppl.):2002;285-286
32. Buckley S., Barsky L., Driscoll B., Weinberg K., Anderson K.D., Warburton D. Apoptosis and DNA damage in type 2 alveolar epithelial cells cultured from hyperoxic rats. Am. J. Physiol. 274:1998;L714-L720
33. Burgess W.H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:1989;575-606
34. Hi T cell transfer mouse models of inflammatory bowel disease. Am. J. Physiol. Gastrointest. Liver Physiol. 282:2002;G690-G701
35. Cardoso W.V., Itoh A., Nogawa H., Mason I., Brody J.S. FGF-1 and FGF-7 induce distinct patterns of growth and differentiation in embryonic lung epithelium. Dev. Dyn. 208:1997;398-405
36. Carstens R.P., Eaton J.V., Krigman H.R., Walther P.J., Garcia-Blanco M.A. Alternative splicing of fibroblast growth factor receptor 2 (FGFR-2) in human prostate cancer. Oncogene. 15:1997;3059-3065
37. Carstens R.P., McKeehan W.L., Garcia-Blanco M.A. An intronic sequence element mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing. Mol. Cell. Biol. 18:1998;2205-2217
38. Carstens R.P., Wagner E.J., Garcia-Blanco M.A. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein. Mol. Cell. Biol. 20:2000;7388-7400
39. Casci T., Vinos J., Freeman M. Sprouty, an intracellular inhibitor of ras signaling. Cell. 96:1999;655-665
40. Celli G., LaRochelle W.J., Mackem S., Sharp R., Merlino G. Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J. 17:1998;1642-1655
41. Chandrasekher G., Kakazu A.H., Bazan H.E. HGF- and KGF-induced activation of PI-3Kp70 S6 kinase pathway in corneal epithelial cells: Its relevance in wound healing. Exp. Eye Res. 73:2001;191-202
42. Chang Z., Meyer K., Rapraeger A.C., Friedl A. Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J. 14:2000;137-144
43. Charafeddine L., D'Angio C.T., Richards J.L., Stripp B.R., Finkelstein J.N., Orlowski C.C., LoMonaco M.B., Paxhia A., Ryan R.M. Hyperoxia increases keratinocyte growth factor mRNA expression in neonatal rabbit lung. Am. J. Physiol. 276:1999;L105-L113
44. Chedid M., Rubin J.S., Csaky K.G., Aaronson S.A. Regulation of keratinocyte growth factor gene expression by interleukin 1. J. Biol. Chem. 269:1994;10753-10757
45. Chedid M., Hoyle J.R., Csaky K.G., Rubin J.S. Glucocorticoids inhibit keratinocyte growth factor production in primary dermal fibroblasts. Endocrinology. 137:1996;2232-2237
46. Chelly N., Mouhieddine-Gueddiche O.B., Barlier-Mur A.M., Chailley-Heu B., Bourbon J.R. Keratinocyte growth factor enhances maturation of fetal rat lung type II cells. Am. J. Respir. Cell Mol. Biol. 20:1999;423-432
47. Chelly N., Henrion A., Pinteur C., Chailley-Heu B., Bourbon J.R. Role of keratinocyte growth factor in the control of surfactant synthesis by fetal lung mesenchyme. Endocrinology. 142:2001;1814-1819
48. Chen Y., Chou K., Fuchs E., Havran W.L., Boismenu R. Protection of the intestinal mucosa by intraepithelial γδ T cells. Proc. Natl. Acad. Sci. USA. 99:2002;14338-14343
49. Cheon H.G., LaRochelle W.J., Bottaro D.P., Burgess W.H., Aaronson S.A. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains. Proc. Natl. Acad. Sci. USA. 91:1994;989-993
50. Clarke S.J., Abdi E., Davis I.D., Schnell F.M., Zalcberg J.R., Gutheil J., Serdar C., Yao B., Heard R., Meropol N., Rosen L.S. Recombinant human keratinocyte growth factor (rHuKGF) prevents chemotherapy-induced mucositis in patients with advanced colorectal cancer: A randomized phase II trial [abstract 1529]. Proc. Am. Soc. Clin. Oncol. 20:2001;383a
51. Corfield A.P., Myerscough N., Longman R., Sylvester P., Arul S., Pignatelli M. Mucins and mucosal protection in the gastrointestinal tract: New prospects for mucins in the pathology of gastrointestinal disease. Gut. 47:2000;589-594
52. Cunha G.R., Chung L.W., Shannon J.M., Taguchi O., Fujii H. Hormone-induced morphogenesis and growth: Role of mesenchymal-epithelial interactions. Recent Prog. Horm. Res. 39:1983;559-598
53. Danilenko D.M. Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol. Pathol. 27:1999;64-71
54. Danilenko D.M., Ring B.D., Tarpley J.E., Morris B., Van G.Y., Morawiecki A., Callahan W., Goldenberg M., Hershenson S., Pierce G.F. Growth factors in porcine full and partial thickness burn repair: Differing targets and effects of keratinocyte growth factor, platelet-derived growth factor-BB, epidermal growth factor, and Neu differentiation factor. Am. J. Pathol. 147:1995a;1261-1277
55. Danilenko D.M., Ring B.D., Yanagihara D., Benson W., Wiemann B., Starnes C.O., Pierce G.F. Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation: Normalization of the nunu follicular differentiation defect and amelioration of chemotherapy-induced alopecia. Am. J. Pathol. 147:1995b;145-154
56. Del Gatto F., Plet A., Gesnel M.C., Fort C., Breathnach R. Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 17:1997;5106-5116
57. De Moerlooze L., Spencer-Dene B., Revest J., Hajihosseini M., Rosewell I., Dickson C. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development. 127:2000;483-492
58. Deterding R.R., Havill A.M., Yano T., Middleton S.C., Jacoby C.R., Shannon J.M., Simonet W.S., Mason R.J. Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Proc. Assoc. Am. Physicians. 109:1997;254-268
59. Dhalluin C., Yan K., Plotnikova O., Lee K.W., Zeng L., Kuti M., Mujtaba S., Goldfarb M.P., Zhou M.M. Structural basis of SNT PTB domain interactions with distinct neurotrophic receptors. Mol. Cell. 6:2000;921-929
60. Diez de Medina S.G., Chopin D., El Marjou A., Delouvee A., LaRochelle W.J., Hoznek A., Abbou C., Aaronson S.A., Thiery J.P., Radvanyi F. Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas. Oncogene. 14:1997;323-330
61. Dixon A.E., Mandac J.B., Madtes D.K., Martin P.J., Clark J.G. Chemokine expression in TH1 cell-induced lung injury: Prominence of IFN-γ-inducible chemokines. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L592-L599
62. Dörr W., Noack R., Spekl K., Farrell C.L. Modification of oral mucositis by keratinocyte growth factor: Single radiation exposure. Int. J. Radiat. Biol. 77:2001;341-347
63. Dörr W., Spekl K., Farrell C.L. Amelioration of acute oral mucositis by keratinocyte growth factor: Fractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 54:2002a;245-251
64. Dörr W., Spekl K., Farrell C.L. The effect of keratinocyte growth factor on healing of manifest radiation ulcers in mouse tongue epithelium. Cell Prolif. 35:(Suppl. 1):2002b;86-92
65. Duncan M., Grant G. Oral and intestinal mucositis: Causes and possible treatments. Aliment. Pharmacol. Ther. 18:2003;853-874
66. Durrant S., Pico J.L., Schmitz N., Blaise D., Harousseau J.L., Szer J., Boogaerts M., Finke J., Goldstone A.H., Borkett K., Heard R.G., et al. A phase I study of recombinant human keratinocyte growth factor (rHuKGF) in lymphoma patients receiving high-dose chemotherapy (HDC) with autologous peripheral blood progenitor cell transplantation (autoPBPCT) [abstract 3130]. Blood. 94:(Suppl. 1):1999;708a
67. Egger B., Tolmos J., Procaccino F., Sarosi I., Friess H., Buchler M.W., Stamos M., Eysselein V.E. Keratinocyte growth factor promotes healing of left-sided colon anastomoses. Am. J. Surg. 176:1998;18-24
68. Egger B., Procaccino F., Sarosi I., Tolmos J., Buchler M.W., Eysselein V.E. Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice. Dig. Dis. Sci. 44:1999;836-844
69. Egger B., Inglin R., Zeeh J., Dirsch O., Huang Y., Buchler M.W. Insulin-like growth factor I and truncated keratinocyte growth factor accelerate healing of left-sided colonic anastomoses. Br. J. Surg. 88:2001;90-98
70. Elghazi L., Cras-Meneur C., Czernichow P., Scharfmann R. Role for FGFR2IIIb-mediated signals in controlling pancreatic endocrine progenitor cell proliferation. Proc. Natl. Acad. Sci. USA. 99:2002;3884-3889
71. Emoto H., Tagashira S., Mattei M.G., Yamasaki M., Hashimoto G., Katsumata T., Negoro T., Nakatsuka M., Birnbaum D., Coulier F., Itoh N. Structure and expression of human fibroblast growth factor-10. J. Biol. Chem. 272:1997;23191-23194
72. Erickson M., Morkowski S., Lehar S., Gillard G., Beers C., Dooley J., Rubin J.S., Rudensky A., Farr A.G. Regulation of thymic epithelium by keratinocyte growth factor. Blood. 100:2002;3269-3278
73. Eriksson A.E., Cousens L.S., Weaver L.H., Matthews B.W. Three-dimensional structure of human basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA. 88:1991;3441-3445
74. Estivariz C.F., Gu L.H., Scully S., Eli A., Jonas C.R., Farrell C.L., Ziegler T.R. Regulation of keratinocyte growth factor (KGF) and KGF receptor mRNAs by nutrient intake and KGF administration in rat intestine. Dig. Dis. Sci. 45:2000;736-743
75. Faham S., Hileman R.E., Fromm J.R., Linhardt R.J., Rees D.C. Heparin structure and interactions with basic fibroblast growth factor. Science. 271:1996;1116-1120
76. Farrell C.L., Bready J.V., Rex K.L., Chen J.N., DiPalma C.R., Whitcomb K.L., Yin S., Hill D.C., Wiemann B., Starnes C.O., Havill A.M., Lu Z.N., Aukerman S.L., Pierce G.F., Thomason A., Potten C.S., Ulich T.R., Lacey D.L. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res. 58:1998;933-939
77. Farrell C.L., Rex K.L., Kaufman S.A., Dipalma C.R., Chen J.N., Scully S., Lacey D.L. Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice. Int. J. Radiat. Biol. 75:1999;609-620
78. Farrell C.L., Rex K.L., Chen J.N., Bready J.V., DiPalma C.R., Kaufman S.A., Rattan A., Scully S., Lacey D.L. The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif. 35:(Suppl. 1):2002;78-85
79. Fasciana C., van der Made A.C., Faber P.W., Trapman J. Androgen regulation of the rat keratinocyte growth factor (KGFFGF7) promoter. Biochem. Biophys. Res. Commun. 220:1996;858-863
80. Fassett J.T., Nilsen-Hamilton M. Mrp3, a mitogen-regulated proteinproliferin gene expressed in wound healing and in hair follicles. Endocrinology. 142:2001;2129-2137
81. Fehrenbach H., Kasper M., Tschernig T., Pan T., Schuh D., Shannon J.M., Muller M., Mason R.J. Keratinocyte growth factor-induced hyperplasia of rat alveolar type II cells in vivo is resolved by differentiation into type I cells and by apoptosis. Eur. Respir. J. 14:1999;534-544
82. Fernandez-Estivariz C., Gu L.H., Gu L., Jonas C.R., Wallace T.M., Pascal R.R., Devaney K.L., Farrell C.L., Jones D.P., Podolsky D.K., Ziegler T.R. Trefoil peptide expression and goblet cell number in rat intestine: Effects of KGF and fasting-refeeding. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:2003;R564-R573
83. Finch P.W., Rubin J.S., Miki T., Ron D., Aaronson S.A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science. 245:1989;752-755
84. Finch P.W., Cunha G.R., Rubin J.S., Wong J., Ron D. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev. Dyn. 203:1995a;223-240
85. Finch P.W., Lengel C., Chedid M. Cloning and characterization of the promoter region of the human keratinocyte growth factor gene. J. Biol. Chem. 270:1995b;11230-11237
86. Finch P.W., Pricolo V., Wu A., Finkelstein S.D. Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology. 110:1996;441-451
87. Finch P.W., Murphy F., Cardinale I., Krueger J.G. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am. J. Pathol. 151:1997;1619-1628
88. Foad B.S., Hess E.V. Urinary bladder complications with cyclophosphamide therapy. Arch. Intern. Med. 136:1976;616-619
89. Fong C.W., Leong H.F., Wong E.S., Lim J., Yusoff P., Guy G.R. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. J. Biol. Chem. 278:2003;33456-33464
90. Foster B.A., Evangelou A., Gingrich J.R., Kaplan P.J., DeMayo F., Greenberg N.M. Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2IIIb promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice. Differentiation. 70:2002;624-632
91. Frank S., Werner S. The human homologue of the yeast CHL1 gene is a novel keratinocyte growth factor-regulated gene. J. Biol. Chem. 271:1996;24337-24340
92. Frank S., Munz B., Werner S. The human homologue of a bovine non-selenium glutathione peroxidase is a novel keratinocyte growth factor-regulated gene. Oncogene. 14:1997;915-921
93. Friedl A., Chang Z., Tierney A., Rapraeger A.C. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: Comparison of normal and abnormal human tissues. Am. J. Pathol. 150:1997;1443-1455
94. Galiacy S., Planus E., Lepetit H., Fereol S., Laurent V., Ware L., Isabey D., Matthay M., Harf A., d'Ortho M.P. Keratinocyte growth factor promotes cell motility during alveolar epithelial repair in vitro. Exp. Cell Res. 283:2003;215-229
95. Gassmann M.G., Werner S. Caveolin-1 and -2 expression is differentially regulated in cultured keratinocytes and within the regenerating epidermis of cutaneous wounds. Exp. Cell Res. 258:2000;23-32
96. Gassmann M.G., Stanzel A., Werner S. Growth factor-regulated expression of enzymes involved in nucleotide biosynthesis: A novel mechanism of growth factor action. Oncogene. 18:1999;6667-6676
97. Ghiselli G., Eichstetter I., Iozzo R.V. A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor. Biochem. J. 359:2001;153-163
98. Gibson R.J., Keefe D.M., Clarke J.M., Regester G.O., Thompson F.M., Goland G.J., Edwards B.G., Cummins A.G. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother. Pharmacol. 50:2002;53-58
99. Gilbert E., Del Gatto F., Champion-Arnaud P., Gesnel M.C., Breathnach R. Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA. Mol. Cell. Biol. 13:1993;5461-5468
100. Gillis P., Savla U., Volpert O.V., Jimenez B., Waters C.M., Panos R.J., Bouck N.P. Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J. Cell Sci. 112:1999;2049-2057
101. Graves B.J., Hatada M.H., Hendrickson W.A., Miller J.K., Madison V.S., Satow Y. Structure of interleukin 1α at 2.7-Å resolution. Biochemistry. 29:1990;2679-2684
102. Gray T.E., Eisenstein M., Shimon T., Givol D., Yayon A. Molecular modeling based mutagenesis defines ligand binding and specificity determining regions of fibroblast growth factor receptors. Biochemistry. 34:1995;10325-10333
103. Gross I., Bassit B., Benezra M., Licht J.D. Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J. Biol. Chem. 276:2001;46460-46468
104. Guery B.P., Mason C.M., Dobard E.P., Beaucaire G., Summer W.R., Nelson S. Keratinocyte growth factor increases transalveolar sodium reabsorption in normal and injured rat lungs. Am. J. Respir. Crit. Care Med. 155:1997;1777-1784
105. Guimond S., Maccarana M., Olwin B.B., Lindahl U., Rapraeger A.C. Activating and inhibitory heparin sequences for FGF-2 (basic FGF): Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268:1993;23906-23914
106. Guo J., Yi E.S., Havill A.M., Sarosi I., Whitcomb L., Yin S., Middleton S.C., Piguet P., Ulich T.R. Intravenous keratinocyte growth factor protects against experimental pulmonary injury. Am. J. Physiol. 275:1998;L800-L805
107. Guo L., Yu Q.C., Fuchs E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J. 12:1993;973-986
108. Guo L., Degenstein L., Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 10:1996;165-175
109. Hacohen N., Kramer S., Sutherland D., Hiromi Y., Krasnow M.A. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell. 92:1998;253-263
110. Hadari Y.R., Kouhara H., Lax I., Schlessinger J. Binding of SHP2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol. Cell. Biol. 18:1998;3966-3973
111. Haddad I.Y., Milla C., Yang S., Panoskaltsis-Mortari A., Hawgood S., Lacey D.L., Blazar B.R. Surfactant protein A is a required mediator of keratinocyte growth factor after experimental marrow transplantation. Am. J. Physiol. Lung Cell Mol. Physiol. 285:2003;L602-L610
112. Halaban R., Funasaka Y., Lee P., Rubin J., Ron D., Birnbaum D. Fibroblast growth factors in normal and malignant melanocytes. Ann. N.Y. Acad. Sci. 638:1991;232-243
113. Hanafusa H., Torii S., Yasunaga T., Nishida E. Sprouty1 and sprouty2 provide a control mechanism for the rasMAPK signalling pathway. Nat. Cell Biol. 4:2002;850-858
114. Hashimoto S., Nakano H., Singh G., Katyal S. Expression of Spred and Sprouty in developing rat lung. Mech. Dev. 119:(Suppl. 1):2002;S303-S309
115. Hattori Y., Itoh H., Uchino S., Hosokawa K., Ochiai A., Ino Y., Ishii H., Sakamoto H., Yamaguchi N., Yanagihara K., Hirohashi S., Sugimura T., Terada M. Immunohistochemical detection of K-SAM protein in stomach cancer. Clin. Cancer Res. 2:1996;1373-1381
116. He Y., Crouch E. Surfactant protein D gene regulation: Interactions among the conserved CCAATenhancer-binding protein elements. J. Biol. Chem. 277:2002;19530-19537
117. Hill G.R., Ferrara J.L. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 95:2000;2754-2759
118. Hille A., Rave-Frank M., Pradier O., Damm C., Dörr W., Jackel M.C., Christiansen H., Hess C.F., Schmidberger H. Effect of keratinocyte growth factor on the proliferation, clonogenic capacity and colony size of human epithelial tumour cells in vitro. Int. J. Radiat. Biol. 79:2003;119-128
119. Hines M.D., Allen-Hoffmann B.L. Keratinocyte growth factor inhibits cross-linked envelope formation and nucleosomal fragmentation in cultured human keratinocytes. J. Biol. Chem. 271:1996;6245-6251
120. Housley R.M., Morris C.F., Boyle W., Ring B., Biltz R., Tarpley J.E., Aukerman S.L., Devine P.L., Whitehead R.H., Pierce G.F. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J. Clin. Invest. 94:1994;1764-1777
121. Hsu Y.R., Nybo R., Sullivan J.K., Costigan V., Spahr C.S., Wong C., Jones M., Pentzer A.G., Crouse J.A., Pacifici R.E., Lu H.S., Morris C.F., Philo J.S. Heparin is essential for a single keratinocyte growth factor molecule to bind and form a complex with two molecules of the extracellular domain of its receptor. Biochemistry. 38:1999;2523-2534
122. Ichimura T., Finch P.W., Zhang G., Kan M., Stevens J.L. Induction of FGF-7 after kidney damage: A possible paracrine mechanism for tubule repair. Am. J. Physiol. 271:1996;F967-F976
123. Igarashi M., Finch P.W., Aaronson S.A. Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). J. Biol. Chem. 273:1998;13230-13235
124. Imagawa W., Pedchenko V.K., Helber J., Xing C. Attenuation and loss of hormonal modulation of KGF (FGF-7)KGF receptor expression and mitogenesis during mammary tumor progression. J. Cell. Physiol. 184:2000;222-228
125. Impagnatiello M.A., Weitzer S., Gannon G., Compagni A., Cotten M., Christofori G. Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J. Cell Biol. 152:2001;1087-1098
126. Isakson B.E., Lubman R.L., Seedorf G.J., Boitano S. Modulation of pulmonary alveolar type II cell phenotype and communication by extracellular matrix and KGF. Am. J. Physiol. Cell Physiol. 281:2001;C1291-C1299
127. Ishii H., Yoshida T., Oh H., Yoshida S., Terada M. A truncated K-SAM product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation. Mol. Cell. Biol. 15:1995;3664-3671
128. Ishiwata T., Friess H., Buchler M.W., Lopez M.E., Korc M. Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am. J. Pathol. 153:1998;213-222
129. Itoh H., Hattori Y., Sakamoto H., Ishii H., Kishi T., Sasaki H., Yoshida T., Koono M., Sugimura T., Terada M. Preferential alternative splicing in cancer generates a K-SAM messenger RNA with higher transforming activity. Cancer Res. 54:1994;3237-3241
130. Iwakiri D., Podolsky D.K. Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor. Gastroenterology. 120:2001;1372-1380
131. Izvolsky K.I., Shoykhet D., Yang Y., Yu Q., Nugent M.A., Cardoso W.V. Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev. Biol. 258:2003a;185-200
132. Izvolsky K.I., Zhong L., Wei L., Yu Q., Nugent M.A., Cardoso W.V. Heparan sulfates expressed in the distal lung are required for FGF-10 binding to the epithelium and for airway branching. Am. J. Physiol. Lung Cell Mol. Physiol. 285:2003b;L838-L846
133. Jacquemier J., Sun Z.Z., Penault-Llorca F., Geneix J., Devilard E., Adelaide J., Birnbaum D. FGF7 protein expression in human breast carcinomas. J. Pathol. 186:1998;269-274
134. Jameson J., Ugarte K., Chen N., Yachi P., Fuchs E., Boismenu R., Havran W.L. A role for skin γδ T cells in wound repair. Science. 296:2002;747-749
135. Jeschke M.G., Richter G., Hofstadter F., Herndon D.N., Perez-Polo J.R., Jauch K.W. Non-viral liposomal keratinocyte growth factor (KGF) cDNA gene transfer improves dermal and epidermal regeneration through stimulation of epithelial and mesenchymal factors. Gene Ther. 9:2002;1065-1074
136. Johnson D.E., Williams L.T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1993;1-41
137. Jonas C.R., Farrell C.L., Scully S., Eli A., Estivariz C.F., Gu L.H., Jones D.P., Ziegler T.R. Enteral nutrition and keratinocyte growth factor regulate expression of glutathione-related enzyme messenger RNAs in rat intestine. JPEN J. Parenter. Enteral Nutr. 24:2000;67-75
138. Ka H., Spencer T.E., Johnson G.A., Bazer F.W. Keratinocyte growth factor: Expression by endometrial epithelia of the porcine uterus. Biol. Reprod. 62:2000;1772-1778
139. Kelley M.J., Pech M., Seuanez H.N., Rubin J.S., O'Brien S.J., Aaronson S.A. Emergence of the keratinocyte growth factor multigene family during the great ape radiation. Proc. Natl. Acad. Sci. USA. 89:1992;9287-9291
140. Khan W.B., Shui C., Ning S., Knox S.J. Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Radiat. Res. 148:1997;248-253
141. Kim H.S. The human FGF gene family: Chromosome location and phylogenetic analysis. Cytogenet. Cell Genet. 93:2001;131-132
142. Kim P.J., Sakaguchi K., Sakamoto H., Saxinger C., Day R., McPhie P., Rubin J.S., Bottaro D.P. Colocalization of heparin and receptor binding sites on keratinocyte growth factor. Biochemistry. 37:1998;8853-8862
143. Kitsberg D.I., Leder P. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene. 13:1996;2507-2515
144. Klagsbrun M., Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 67:1991;229-231
145. Koji T., Chedid M., Rubin J.S., Slayden O.D., Csaky K.G., Aaronson S.A., Brenner R.M. Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: Keratinocyte growth factor as a progestomedin. J. Cell Biol. 125:1994;393-401
146. Kouhara H., Hadari Y.R., Spivak-Kroizman T., Schilling J., Bar-Sagi D., Lax I., Schlessinger J. A lipid-anchored GRB2-binding protein that links FGF-receptor activation to the RasMAPK signaling pathway. Cell. 89:1997;693-702
147. Krakowski M.L., Kritzik M.R., Jones E.M., Krahl T., Lee J., Arnush M., Gu D., Sarvetnick N. Pancreatic expression of keratinocyte growth factor leads to
148. Kramer S., Okabe M., Hacohen N., Krasnow M.A., Hiromi Y. Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila. Development. 126:1999;2515-2525
149. Krenger W., Hill G.R., Ferrara J.L. Cytokine cascades in acute graft-versus-host disease. Transplantation. 64:1997;553-558
150. Kreuger J., Salmivirta M., Sturiale L., Gimenez-Gallego G., Lindahl U. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J. Biol. Chem. 276:2001;30744-30752
151. Krijanovski O.I., Hill G.R., Cooke K.R., Teshima T., Crawford J.M., Brinson Y.S., Ferrara J.L. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood. 94:1999;825-831
152. LaRochelle W.J., Sakaguchi K., Atabey N., Cheon H.G., Takagi Y., Kinaia T., Day R.M., Miki T., Burgess W.H., Bottaro D.P. Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor. Biochemistry. 38:1999;1765-1771
153. Larsson H., Klint P., Landgren E., Claesson-Welsh L. Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2SH3 domain-containing adaptor protein Crk. J. Biol. Chem. 274:1999;25726-25734
154. Leeksma O.C., Van Achterberg T.A., Tsumura Y., Toshima J., Eldering E., Kroes W.G., Mellink C., Spaargaren M., Mizuno K., Pannekoek H., de Vries C.J. Human Sprouty 4, a new Ras antagonist on 5q31, interacts with the dual specificity kinase TESK1. Eur. J. Biochem. 269:2002;2546-2556
155. Leung H.Y., Mehta P., Gray L.B., Collins A.T., Robson C.N., Neal D.E. Keratinocyte growth factor expression in hormone insensitive prostate cancer. Oncogene. 15:1997;1115-1120
156. Levine A.C., Liu X.-H., Ren M., Wang J.-P., Schiff J.D., Diamond E.J., Finch P.W., Aaronson S.A., Kirschenbaum A. Androgenic effects on prostate specific antigen secretion by human fetal prostate are mediated by keratinocyte growth factor. Mol. Urol. 2:1998;71-78
157. Li F., Rosenberg E., Smith C.I., Notarfrancesco K., Reisher S.R., Shuman H., Feinstein S.I. Correlation of expression of transcription factor cEBPα and surfactant protein genes in lung cells. Am. J. Physiol. 269:1995;L241-L247
158. Liang Q., Mohan R.R., Chen L., Wilson S.E. Signaling by HGF and KGF in corneal epithelial cells: RasMAP kinase and JAK-STAT pathways. Invest. Ophthalmol. Vis. Sci. 39:1998;1329-1338
159. Lim J., Wong E.S., Ong S.H., Yusoff P., Low B.C., Guy G.R. Sprouty proteins are targeted to membrane ruffles upon growth factor receptor tyrosine kinase activation: Identification of a novel translocation domain. J. Biol. Chem. 275:2000;32837-32845
160. Lovicu F.J., Kao W.W., Overbeek P.A. Ectopic gland induction by lens-specific expression of keratinocyte growth factor (FGF-7) in transgenic mice. Mech. Dev. 88:1999;43-53
161. Lu W., Luo Y., Kan M., McKeehan W.L. Fibroblast growth factor-10: A second candidate stromal to epithelial cell andromedin in prostate. J. Biol. Chem. 274:1999;12827-12834
162. Lu Y., Pan Z.Z., Devaux Y., Ray P. P21-activated protein kinase 4 (PAK4) interacts with the keratinocyte growth factor receptor and participates in keratinocyte growth factor-mediated inhibition of oxidant-induced cell death. J. Biol. Chem. 278:2003;10374-10380
163. Maas-Szabowski N., Shimotoyodome A., Fusenig N.E. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J. Cell Sci. 112:1999;1843-1853
164. Maas-Szabowski N., Stark H.J., Fusenig N.E. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J. Invest. Dermatol. 114:2000;1075-1084
165. Maatta A., Jaakkola P., Jalkanen M. Extracellular matrix-dependent activation of syndecan-1 expression in keratinocyte growth factor-treated keratinocytes. J. Biol. Chem. 274:1999;9891-9898
166. MacDonald K.P., Hill G.R. Keratinocyte growth factor (KGF) in hematology and oncology. Curr. Pharm. Des. 8:2002;395-403
167. Madlener M., Mauch C., Conca W., Brauchle M., Parks W.C., Werner S. Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: Implications for normal and impaired wound healing. Biochem. J. 320:1996;659-664
168. Mailleux A.A., Tefft D., Ndiaye D., Itoh N., Thiery J.P., Warburton D., Bellusci S. Evidence that Sprouty2 functions as an inhibitor of mouse embryonic lung growth and morphogenesis. Mech. Dev. 102:2001;81-94
169. Mansukhani A., Dell'Era P., Moscatelli D., Kornbluth S., Hanafusa H., Basilico C. Characterization of the murine BEK fibroblast growth factor (FGF) receptor: Activation by three members of the FGF family and requirement for heparin. Proc. Natl. Acad. Sci. USA. 89:1992;3305-3309
170. Marchese C., Rubin J., Ron D., Faggioni A., Torrisi M.R., Messina A., Frati L., Aaronson S.A. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: Differentiation response distinguishes KGF from EGF family. J. Cell. Physiol. 144:1990;326-332
171. Marchese C., Chedid M., Dirsch O.R., Csaky K.G., Santanelli F., Latini C., LaRochelle W.J., Torrisi M.R., Aaronson S.A. Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J. Exp. Med. 182:1995;1369-1376
172. Marchese C., Sorice M., De Stefano C., Frati L., Torrisi M.R. Modulation of keratinocyte growth factor receptor expression in human cultured keratinocytes. Cell Growth Differ. 8:1997;989-997
173. Mason C.M., Guery B.P., Summer W.R., Nelson S. Keratinocyte growth factor attenuates lung leak induced by α-naphthylthiourea in rats. Crit. Care Med. 24:1996;925-931
174. Mason I.J., Fuller-Pace F., Smith R., Dickson C. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech. Dev. 45:1994;15-30
175. Mason R.J., Lewis M.C., Edeen K.E., McCormick-Shannon K., Nielsen L.D., Shannon J.M. Maintenance of surfactant protein A and D secretion by rat alveolar type II cells in vitro. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L249-L258
176. Mason R.J., Pan T., Edeen K.E., Nielsen L.D., Zhang F., Longphre M., Eckart M.R., Neben S. Keratinocyte growth factor and the transcription factors cEBPα, cEBPδ, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells. J. Clin. Invest. 112:2003;244-255
177. Matsubara A., Kan M., Feng S., McKeehan W.L. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res. 58:1998;1509-1514
178. McGarvey T.W., Stearns M.E. Keratinocyte growth factor and receptor mRNA expression in benign and malignant human prostate. Exp. Mol. Pathol. 63:1995;52-62
179. McKeehan W.L., Wang F., Kan M. The heparan sulfate-fibroblast growth factor family: Diversity of structure and function. Prog. Nucleic Acid Res. Mol. Biol. 59:1998;135-176
180. Meakin S.O., MacDonald J.I., Gryz E.A., Kubu C.J., Verdi J.M. The signaling adapter FRS-2 competes with Shc for binding to the nerve growth factor receptor TrkA: A model for discriminating proliferation and differentiation. J. Biol. Chem. 274:1999;9861-9870
181. Mehta P.B., Robson C.N., Neal D.E., Leung H.Y. Keratinocyte growth factor activates p38 MAPK to induce stress fiber formation in human prostate DU145 cells. Oncogene. 20:2001;5359-5365
182. Meropol N.J., Somer R.A., Gutheil J., Pelley R.J., Modiano M.R., Rowinsky E.K., Rothenberg M.L., Redding S.W., Serdar C.M., Yao B., Heard R., Rosen L.S. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: Potential role as mucosal protectant. J. Clin. Oncol. 21:2003;1452-1458
183. Miki T., Fleming T.P., Bottaro D.P., Rubin J.S., Ron D., Aaronson S.A. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science. 251:1991;72-75
184. Min D., Taylor P.A., Panoskaltsis-Mortari A., Chung B., Danilenko D.M., Farrell C., Lacey D.L., Blazar B.R., Weinberg K.I. Protection from thymic epithelial cell injury by keratinocyte growth factor: A new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 99:2002;4592-4600
185. Miralles F., Czernichow P., Ozaki K., Itoh N., Scharfmann R. Signaling through fibroblast growth factor receptor 2b plays a key role in the development of the exocrine pancreas. Proc. Natl. Acad. Sci. USA. 96:1999;6267-6272
186. 1. Mol. Cell. Biol. 11:1991;5068-5078
187. Mongiat M., Taylor K., Otto J., Aho S., Uitto J., Whitelock J.M., Iozzo R.V. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem. 275:2000;7095-7100
188. Mulcahy R.T., Wartman M.A., Bailey H.H., Gipp J.J. Constitutive and β-naphthoflavone-induced expression of the human γ-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response elementTRE sequence. J. Biol. Chem. 272:1997;7445-7454
189. Nakatake Y., Hoshikawa M., Asaki T., Kassai Y., Itoh N. Identification of a novel fibroblast growth factor, FGF-22, preferentially expressed in the inner root sheath of the hair follicle. Biochim. Biophys. Acta. 1517:2001;460-463
190. Nemeth J.A., Zelner D.J., Lang S., Lee C. Keratinocyte growth factor in the rat ventral prostate: Androgen-independent expression. J. Endocrinol. 156:1998;115-125
191. Nguyen H.Q., Danilenko D.M., Bucay N., DeRose M.L., Van G.Y., Thomason A., Simonet W.S. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. Oncogene. 12:1996;2109-2119
192. Ning S., Shui C., Khan W.B., Benson W., Lacey D.L., Knox S.J. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;177-187
193. Nybo R.E., Everton E.N., Morris C.F. Mitogenic activity of keratinocyte growth factor amino-terminal truncation mutants: Deletion of amino acid residues 1-15 through 1-27. In Vitro Cell Dev. Biol. Anim. 33:1997;606-607
194. Ohuchi H., Hori Y., Yamasaki M., Harada H., Sekine K., Kato S., Itoh N. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem. Biophys. Res. Commun. 277:2000;643-649
195. Onda M., Naito Z., Wang R., Fujii T., Kawahara K., Ishiwata T., Sugisaki Y. Expression of keratinocyte growth factor receptor (KGFRFGFR2 IIIb) in vascular smooth muscle cells. Pathol. Int. 53:2003;127-132
196. Ong S.H., Guy G.R., Hadari Y.R., Laks S., Gotoh N., Schlessinger J., Lax I. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell. Biol. 20:2000;979-989
197. Ornitz D.M., Itoh N. Fibroblast growth factors. Genome Biol. 2:2001;. Reviews3005.1-Reviews3005.12
198. Ornitz D.M., Yayon A., Flanagan J.G., Svahn C.M., Levi E., Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12:1992;240-247
199. Ornitz D.M., Xu J., Colvin J.S., McEwen D.G., MacArthur C.A., Coulier F., Gao G., Goldfarb M. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271:1996;15292-15297
200. Orr-Urtreger A., Bedford M.T., Burakova T., Arman E., Zimmer Y., Yayon A., Givol D., Lonai P. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol. 158:1993;475-486
201. Osslund T.D., Syed R., Singer E., Hsu E.W., Nybo R., Chen B.L., Harvey T., Arakawa T., Narhi L.O., Chirino A., Morris C.F. Correlation between the 1.6 Å crystal structure and mutational analysis of keratinocyte growth factor. Protein Sci. 7:1998;1681-1690
202. Ostrovsky O., Berman B., Gallagher J., Mulloy B., Fernig D.G., Delehedde M., Ron D. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J. Biol. Chem. 277:2002;2444-2453
203. Otte J.M., Schmitz F., Banasiewicz T., Drews M., Folsch U.R., Herzig K.H. Expression of keratinocyte growth factor and its receptor in colorectal cancer. Eur J. Clin. Invest. 30:2000;222-229
204. Panos R.J., Rubin J.S., Csaky K.G., Aaronson S.A., Mason R.J. Keratinocyte growth factor and hepatocyte growth factorscatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J. Clin. Invest. 92:1993;969-977
205. Panos R.J., Bak P.M., Simonet W.S., Rubin J.S., Smith L.J. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J. Clin. Invest. 96:1995;2026-2033
206. Panoskaltsis-Mortari A., Lacey D.L., Vallera D.A., Blazar B.R. Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood. 92:1998;3960-3967
207. Panoskaltsis-Mortari A., Ingbar D.H., Jung P., Haddad I.Y., Bitterman P.B., Wangensteen O.D., Farrell C.L., Lacey D.L., Blazar B.R. KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT. Am. J. Physiol. Lung Cell Mol. Physiol. 278:2000a;L988-L999
208. Panoskaltsis-Mortari A., Taylor P.A., Rubin J.S., Uren A., Welniak L.A., Murphy W.J., Farrell C.L., Lacey D.L., Blazar B.R. Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury. Blood. 96:2000b;4350-4356
209. Park W.Y., Miranda B., Lebeche D., Hashimoto G., Cardoso W.V. FGF-10 is a chemotactic factor for distal epithelial buds during lung development. Dev. Biol. 201:1998;125-134
210. Parrott J.A., Kim G., Mosher R., Skinner M.K. Expression and action of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer. Mol. Cell. Endocrinol. 167:2000;77-87
211. Pedchenko V.K., Imagawa W. Estrogen treatment in vivo increases keratinocyte growth factor expression in the mammary gland. J. Endocrinol. 165:2000a;39-49
212. Pedchenko V.K., Imagawa W. Pattern of expression of the KGF receptor and its ligands KGF and FGF-10 during postnatal mouse mammary gland development. Mol. Reprod. Dev. 56:2000b;441-447
213. Pellegrini L., Burke D.F., von Delft F., Mulloy B., Blundell T.L. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature. 407:2000;1029-1034
214. Petiot A., Conti F.J., Grose R., Revest J.M., Hodivala-Dilke K.M., Dickson C. A crucial role for FGFR2-IIIb signalling in epidermal development and hair follicle patterning. Development. 130:2003;5493-5501
215. Pierce G.F., Yanagihara D., Klopchin K., Danilenko D.M., Hsu E., Kenney W.C., Morris C.F. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J. Exp. Med. 179:1994;831-840
216. Playford R.J., Marchbank T., Goodlad R.A., Chinery R.A., Poulsom R., Hanby A.M. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl. Acad. Sci. USA. 93:1996;2137-2142
217. Plotnikov A.N., Schlessinger J., Hubbard S.R., Mohammadi M. Structural basis for FGF receptor dimerization and activation. Cell. 98:1999;641-650
218. Post M., Souza P., Liu J., Tseu I., Wang J., Kuliszewski M., Tanswell A.K. Keratinocyte growth factor and its receptor are involved in regulating early lung branching. Development. 122:1996;3107-3115
219. Potten C.S., O'Shea J.A., Farrell C.L., Rex K., Booth C. The effects of repeated doses of keratinocyte growth factor on cell proliferation in the cellular hierarchy of the crypts of the murine small intestine. Cell Growth Differ. 12:2001;265-275
220. Powell A.K., Fernig D.G., Turnbull J.E. Fibroblast growth factor receptors 1 and 2 interact differently with heparinheparan sulfate: Implications for dynamic assembly of a ternary signaling complex. J. Biol. Chem. 277:2002;28554-28563
221. Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer. 7:2000;165-197
222. Prince L.S., Karp P.H., Moninger T.O., Welsh M.J. KGF alters gene expression in human airway epithelia: Potential regulation of the inflammatory response. Physiol. Genomics. 6:2001;81-89
223. Putnins E.E., Firth J.D., Uitto V.J. Keratinocyte growth factor stimulation of gelatinase (matrix metalloproteinase-9) and plasminogen activator in histiotypic epithelial cell culture. J. Invest. Dermatol. 104:1995;989-994
224. Putnins E.E., Firth J.D., Uitto V.J. Stimulation of collagenase (matrix metalloproteinase-1) synthesis in histiotypic epithelial cell culture by heparin is enhanced by keratinocyte growth factor. Matrix Biol. 15:1996;21-29
225. Putnins E.E., Firth J.D., Lohachitranont A., Uitto V.J., Larjava H. Keratinocyte growth factor (KGF) promotes keratinocyte cell attachment and migration on collagen and fibronectin. Cell Adhes. Commun. 7:1999;211-221
226. Pye D.A., Vives R.R., Hyde P., Gallagher J.T. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: Differential requirements for the modulation of FGF-1 and FGF-2. Glycobiology. 10:2000;1183-1192
227. Qiao J., Uzzo R., Obara-Ishihara T., Degenstein L., Fuchs E., Herzlinger D. FGF-7 modulates ureteric bud growth and nephron number in the developing kidney. Development. 126:1999;547-554
228. Rakasz E., Sandor M., Hagen M., Lynch R.G. Activation features of intraepithelial γδ T-cells of the murine vagina. Immunol. Lett. 54:1996;129-134
229. Raman R., Venkataraman G., Ernst S., Sasisekharan V., Sasisekharan R. Structural specificity of heparin binding in the fibroblast growth factor family of proteins. Proc. Natl. Acad. Sci. USA. 100:2003;2357-2362
230. Rapraeger A.C., Krufka A., Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 252:1991;1705-1708
231. Ray P., Devaux Y., Stolz D.B., Yarlagadda M., Watkins S.C., Lu Y., Chen L., Yang X.F., Ray A. Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc. Natl. Acad. Sci. USA. 100:2003;6098-6103
232. Reich A., Sapir A., Shilo B. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development. 126:1999;4139-4147
233. Reich-Slotky R., Bonneh-Barkay D., Shaoul E., Bluma B., Svahn C.M., Ron D. Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor. J. Biol. Chem. 269:1994;32279-32285
234. Reich-Slotky R., Shaoul E., Berman B., Graziani G., Ron D. Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificities. J. Biol. Chem. 270:1995;29813-29818
235. Revest J.M., Suniara R.K., Kerr K., Owen J.J.T., Dickson C. Development of the thymus requires signaling through the fibroblast growth factor receptor R2IIIb. J. Immunol. 167:2001;1954-1961
236. Rice W.R., Conkright J.J., Na C.L., Ikegami M., Shannon J.M., Weaver T.E. Maintenance of the mouse type II cell phenotype in vitro. Am. J. Physiol. Lung Cell Mol. Physiol. 283:2002;L256-L264
237. Ricol D., Cappellen D., El Marjou A., Gil-Diez-de-Medina S., Girault J.M., Yoshida T., Ferry G., Tucker G., Poupon M.F., Chopin D., Thiery J.P., Radvanyi F. Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene. 18:1999;7234-7243
238. Ron D., Bottaro D.P., Finch P.W., Morris D., Rubin J.S., Aaronson S.A. Expression of biologically active recombinant keratinocyte growth factor: Structurefunction analysis of amino-terminal truncation mutants. J. Biol. Chem. 268:1993a;2984-2988
239. Ron D., Reich R., Chedid M., Lengel C., Cohen O.E., Chan A.M., Neufeld G., Miki T., Tronick S.R. Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. J. Biol. Chem. 268:1993b;5388-5394
240. Rossi S., Blazar B.R., Farrell C.L., Danilenko D.M., Lacey D.L., Weinberg K.I., Krenger W., Hollander G.A. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood. 100:2002;682-691
241. Rubin J.S., Osada H., Finch P.W., Taylor W.G., Rudikoff S., Aaronson S.A. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc. Natl. Acad. Sci. USA. 86:1989;802-806
242. Rubin J.S., Bottaro D.P., Chedid M., Miki T., Ron D., Cheon G., Taylor W.G., Fortney E., Sakata H., Finch P.W., et al. Keratinocyte growth factor. Cell Biol. Int. 19:1995;399-411
243. Ruehl M., Somasundaram R., Schoenfelder I., Farndale R.W., Knight C.G., Schmid M., Ackermann R., Riecken E.O., Zeitz M., Schuppan D. The epithelial mitogen keratinocyte growth factor binds to collagens via the consensus sequence glycine-proline-hydroxyproline. J. Biol. Chem. 277:2002;26872-26878
244. Rushmore T.H., King R.G., Paulson K.E., Pickett C.B. Regulation of glutathione S-transferase Ya subunit gene expression: Identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. USA. 87:1990;3826-3830
245. Sasaki A., Taketomi T., Kato R., Saeki K., Nonami A., Sasaki M., Kuriyama M., Saito N., Shibuya M., Yoshimura A. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat. Cell Biol. 5:2003;427-432
246. Savla U., Waters C.M. Barrier function of airway epithelium: Effects of radiation and protection by keratinocyte growth factor. Radiat. Res. 150:1998;195-203
247. Sawyer R.H., Fallow J.F. "Epithelial-Mesenchymal Interaction During Development." 1983;Praeger, New York
248. Schlessinger J., Plotnikov A.N., Ibrahimi O.A., Eliseenkova A.V., Yeh B.K., Yayon A., Linhardt R.J., Mohammadi M. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell. 6:2000;743-750
249. Schor S.L., Schor A.M. Clonal heterogeneity in fibroblast phenotype: Implications for the control of epithelial-mesenchymal interactions. Bioessays. 7:1987;200-204
250. Sekine K., Ohuchi H., Fujiwara M., Yamasaki M., Yoshizawa T., Sato T., Yagishita N., Matsui D., Koga Y., Itoh N., Kato S. FGF10 is essential for limb and lung formation. Nat. Genet. 21:1999;138-141
251. Senaldi G., Shaklee C.L., Simon B., Rowan C.G., Lacey D.L., Hartung T. Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor-induced apoptosis in vivo and in vitro. Hepatology. 27:1998;1584-1591
252. Serdar C.M., Heard R., Prathikanti R., Lau D., Danilenko D., Hunt T., Lacey D. Safety, pharmokinetics and biologic activity of rHuKGF in normal volunteers: Results of a placebo-controlled randomized double-blind phase I study [abstract 761]. Blood. 90:(Suppl. 1):1997;172a
253. Sher I., Weizman A., Lubinsky-Mink S., Lang T., Adir N., Schomburg D., Ron D. Mutations uncouple human fibroblast growth factor (FGF)-7 biological activity and receptor binding and support broad specificity in the secondary receptor binding site of FGFs. J. Biol. Chem. 274:1999;35016-35022
254. Sher I., Lang T., Lubinsky-Mink S., Kuhn J., Adir N., Chatterjee S., Schomburg D., Ron D. Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7. J. Biol. Chem. 275:2000;34881-34886
255. Sher I., Yeh B.K., Mohammadi M., Adir N., Ron D. Structure-based mutational analyses in FGF7 identify new residues involved in specific interaction with FGFR2IIIb. FEBS Lett. 552:2003;150-154
256. Simonet W.S., DeRose M.L., Bucay N., Nguyen H.Q., Wert S.E., Zhou L., Ulich T.R., Thomason A., Danilenko D.M., Whitsett J.A. Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung. Proc. Natl. Acad. Sci. USA. 92:1995;12461-12465
257. Slayden O.D., Rubin J.S., Lacey D.L., Brenner R.M. Effects of keratinocyte growth factor in the endometrium of rhesus macaques during the luteal-follicular transition. J. Clin. Endocrinol. Metab. 85:2000;275-285
258. Smola H., Thiekotter G., Fusenig N.E. Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J. Cell Biol. 122:1993;417-429
259. Sonis S.T. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 34:1998;39-43
260. Spielberger R.T., Stiff P., Emmanouilides C., Yanovich S., Bensinger W., Hedrick E., Noga S., Ziegler T., Keating A., Frankel S., Gentile T., Heard R., Yao B., Elhardt D. Efficacy of recombinant human keratinocyte growth factor (rHuKGF) in reducing mucositis in patients with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation (auto-PBPCT) after radiation-based conditioning: Results of a phase 2 trial [abstract 25]. Proc. Am. Soc. Clin. Oncol. 20:2001;7a
261. Spielberger R.T., Emmanouilides C., Stiff P., Bensinger W., Gentile T., Weisdorf D., Kewalramani T., Shea T., Yanovich S., Hansen K., Noga S., McCarty J., LeMaistre C.F., Heard R., Chen M.-G., Elhardt D., Ford J., Cesano A. Use of recombinant human keratinocyte growth factor (rHuKGF) can reduce severe oral mucositis in patients (pts) with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation (auto-PBPCT) after radiation-based conditioning: Results of a phase 3 trial. Proc. 39th Meeting Am. Soc. Oncol. 22:2003;. abstract 3642
262. Springer B.A., Pantoliano M.W., Barbera F.A., Gunyuzlu P.L., Thompson L.D., Herblin W.F., Rosenfeld S.A., Book G.W. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 269:1994;26879-26884
263. Squier C.A., Kremer M.J. Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monogr. 29:2001;7-15
264. Staiano-Coico L., Krueger J.G., Rubin J.S., D'Limi S., Vallat V.P., Valentino L., Fahey T., Hawes A. III, Kingston G., Madden M.R., Mathwich M., Gottlieb A.B., Aaronson S.A. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J. Exp. Med. 178:1993;865-878
265. Stauber D.J., DiGabriele A.D., Hendrickson W.A. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl. Acad. Sci. USA. 97:2000;49-54
266. Strain A.J., McGuinness G., Rubin J.S., Aaronson S.A. Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: Modulation by heparin. Exp. Cell Res. 210:1994;253-259
267. Sugahara K., Rubin J.S., Mason R.J., Aronsen E.L., Shannon J.M. Keratinocyte growth factor increases mRNAs for SP-A and SP-B in adult rat alveolar type II cells in culture. Am. J. Physiol. 269:1995;L344-L350
268. Sugahara K., Iyama K., Kuroda M.J., Sano K. Double intratracheal instillation of keratinocyte growth factor prevents bleomycin-induced lung fibrosis in rats. J. Pathol. 186:1998;90-98
269. Sugimura Y., Foster B.A., Hom Y.K., Lipschutz J.H., Rubin J.S., Finch P.W., Aaronson S.A., Hayashi N., Kawamura J., Cunha G.R. Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int. J. Dev. Biol. 40:1996;941-951
270. Symonds R.P. Treatment-induced mucositis: An old problem with new remedies. Br. J. Cancer. 77:1998;1689-1695
271. Szabowski A., Maas-Szabowski N., Andrecht S., Kolbus A., Schorpp-Kistner M., Fusenig N.E., Angel P. C-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell. 103:2000;745-755
272. Takeoka M., Ward W.F., Pollack H., Kamp D.W., Panos R.J. KGF facilitates repair of radiation-induced DNA damage in alveolar epithelial cells. Am. J. Physiol. 272:1997;L1174-L1180
273. Tang A., Gilchrest B.A. Regulation of keratinocyte growth factor gene expression in human skin fibroblasts. J. Dermatol. Sci. 11:1996;41-50
274. Taniguchi F., Harada T., Sakamoto Y., Yamauchi N., Yoshida S., Iwabe T., Terakawa N. Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells. J. Clin. Endocrinol. Metab. 88:2003;773-780
275. Tash J.A., David S.G., Vaughan E.E., Herzlinger D.A. Fibroblast growth factor-7 regulates stratification of the bladder urothelium. J. Urol. 166:2001;2536-2541
276. Tefft D., Lee M., Smith S., Crowe D.L., Bellusci S., Warburton D. Msprouty2 inhibits FGF10-activated MAP kinase by differentially binding to upstream target proteins. Am. J. Physiol. Lung Cell Mol. Physiol. 283:2002;L700-L706
277. Thomson A.A., Cunha G.R. Prostatic growth and development are regulated by FGF10. Development. 126:1999;3693-3701
278. Thomson A.A., Foster B.A., Cunha G.R. Analysis of growth factor and receptor mRNA levels during development of the rat seminal vesicle and prostate. Development. 124:1997;2431-2439
279. Tichelaar J.W., Lu W., Whitsett J.A. Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J. Biol. Chem. 275:2000;11858-11864
280. Trowbridge J.M., Rudisill J.A., Ron D., Gallo R.L. Dermatan sulfate binds and potentiates activity of keratinocyte growth factor (FGF-7). J. Biol. Chem. 277:2002;42815-42820
281. Tsuboi R., Sato C., Kurita Y., Ron D., Rubin J.S., Ogawa H. Keratinocyte growth factor (FGF-7) stimulates migration and plasminogen activator activity of normal human keratinocytes. J. Invest. Dermatol. 101:1993;49-53
282. Ueda T., Sasaki H., Aoyagi K., Narikiyo M., Tsubosa Y., Kuwahara Y., Sakamoto H., Mafune K., Yoshida T., Makuuchi M., Terada M. Novel exons located more than 200 kb downstream of the previously described 3′ exon of the K-SAM gene for generating activated forms of KGF receptor. Biochem. Biophys. Res. Commun. 265:1999;739-745
283. Uitto V.J., Airola K., Vaalamo M., Johansson N., Putnins E.E., Firth J.D., Salonen J., Lopez-Otin C., Saarialho-Kere U., Kahari V.M. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am. J. Pathol. 152:1998;1489-1499
284. Ulich T.R., Yi E.S., Longmuir K., Yin S., Biltz R., Morris C.F., Housley R.M., Pierce G.F. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J. Clin. Invest. 93:1994;1298-1306
285. Ulich T.R., Whitcomb L., Tang W., O'Conner Tressel P., Tarpley J., Yi E.S., Lacey D. Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis. Cancer Res. 57:1997;472-475
286. Venkataraman G., Raman R., Sasisekharan V., Sasisekharan R. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Proc. Natl. Acad. Sci. USA. 96:1999;3658-3663
287. 1 gene. Proc. Natl. Acad. Sci. USA. 93:1996;14960-14965
288. Venugopal R., Jaiswal A.K. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene. 17:1998;3145-3156
289. Wagner T. Ifosfamide clinical pharmacokinetics. Clin. Pharmacokinet. 26:1994;439-456
290. Wang J.K., Xu H., Li H.C., Goldfarb M. Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras. Oncogene. 13:1996;721-729
291. Wang F., Lu W., McKeehan K., Mohamedali K., Gabriel J.L., Kan M., McKeehan W.L. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex. Biochemistry. 38:1999a;160-171
292. Wang Y., Folkesson H.G., Jayr C., Ware L.B., Matthay M.A. Alveolar epithelial fluid transport can be simultaneously upregulated by both KGF and β-agonist therapy. J. Appl. Physiol. 87:1999b;1852-1860
293. Ware L.B., Matthay M.A. Keratinocyte and hepatocyte growth factors in the lung: Roles in lung development, inflammation, and repair. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L924-L940
294. Watanabe M., Ishiwata T., Nishigai K., Moriyama Y., Asano G. Overexpression of keratinocyte growth factor in cancer cells and enterochromaffin cells in human colorectal cancer. Pathol. Int. 50:2000;363-372
295. Waters C.M., Savla U. Keratinocyte growth factor accelerates wound closure in airway epithelium during cyclic mechanical strain. J. Cell. Physiol. 181:1999;424-432
296. Waters C.M., Savla U., Panos R.J. KGF prevents hydrogen peroxide-induced
297. Welsh D.A., Summer W.R., Dobard E.P., Nelson S., Mason C.M. Keratinocyte growth factor prevents ventilator-induced lung injury in an ex vivo rat model. Am. J. Respir. Crit. Care Med. 162:2000;1081-1086
298. Weng J., Liang Q., Mohan R.R., Li Q., Wilson S.E. Hepatocyte growth factor, keratinocyte growth factor, and other growth factor-receptor systems in the lens. Invest. Ophthalmol. Vis. Sci. 38:1997;1543-1554
299. Werner S. Keratinocyte growth factor: A unique player in epithelial repair processes. Cytokine Growth Factor Rev. 9:1998;153-165
300. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83:2003;835-870
301. Werner S., Peters K.G., Longaker M.T., Fuller-Pace F., Banda M.J., Williams L.T. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. USA. 89:1992;6896-6900
302. Werner S., Smola H., Liao X., Longaker M.T., Krieg T., Hofschneider P.H., Williams L.T. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science. 266:1994;819-822
303. Wildhaber B.E., Yang H., Teitelbaum D.H. Total parenteral nutrition-induced apoptosis in mouse intestinal epithelium: Modulation by keratinocyte growth factor. J. Surg. Res. 112:2003;144-151
304. Winkles J.A., Alberts G.F., Chedid M., Taylor W.G., DeMartino S., Rubin J.S. Differential expression of the keratinocyte growth factor (KGF) and KGF receptor genes in human vascular smooth muscle cells and arteries. J. Cell. Physiol. 173:1997;380-386
305. Wirth K., Mertelsmann R. Cytoprotective function of keratinocyte growth factor in tumour therapy-induced tissue damage. Br. J. Haematol. 116:2002;505-510
306. Wong E.S., Lim J., Low B.C., Chen Q., Guy G.R. Evidence for direct interaction between Sprouty and CBL. J. Biol. Chem. 276:2001;5866-5875
307. Wong E.S., Fong C.W., Lim J., Yusoff P., Low B.C., Langdon W.Y., Guy G.R. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances RasERK signalling. EMBO J. 21:2002;4796-4808
308. World Health Organization. "Handbook for Reporting Results of Cancer Treatment," 1979;15-22 World Health Organization Geneva
309. 2 exposure. Am. J. Physiol. 275:1998;L780-L787
310. Xu H., Lee K.W., Goldfarb M. Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins. J. Biol. Chem. 273:1998a;17987-17990
311. Xu X., McCormick-Shannon K., Voelker D.R., Mason R.J. KGF increases SP-A and SP-D mRNA levels and secretion in cultured rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 18:1998b;168-178
312. Yan G., Fukabori Y., Nikolaropoulos S., Wang F., McKeehan W.L. Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial- cell andromedin. Mol. Endocrinol. 6:1992;2123-2128
313. Yan G., Fukabori Y., McBride G., Nikolaropolous S., McKeehan W.L. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol. 13:1993;4513-4522
314. Yang S., Panoskaltsis-Mortari A., Ingbar D.H., Matalon S., Zhu S., Resnik E.R., Farrell C.L., Lacey D.L., Blazar B.R., Haddad I.Y. Cyclophosphamide prevents systemic keratinocyte growth factor-induced up-regulation of surfactant protein A after allogeneic transplant in mice. Am. J. Respir. Crit. Care Med. 162:2000;1884-1890
315. Yang H., Wildhaber B., Tazuke Y., Teitelbaum D.H. 2002 Harry M. Vars research award: Keratinocyte growth factor stimulates the recovery of epithelial structure and function in a mouse model of total parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 26:2002;333-340. discussion 340-341
316. Yano T., Deterding R.R., Simonet W.S., Shannon J.M., Mason R.J. Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am. J. Respir. Cell Mol. Biol. 15:1996;433-442
317. Ye S., Luo Y., Lu W., Jones R.B., Linhardt R.J., Capila I., Toida T., Kan M., Pelletier H., McKeehan W.L. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry. 40:2001;14429-14439
318. Yeh B.K., Igarashi M., Eliseenkova A.V., Plotnikov A.N., Sher I., Ron D., Aaronson S.A., Mohammadi M. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proc. Natl. Acad. Sci. USA. 100:2003;2266-2271
319. Yi E.S., Bedoya A.A., Lee H., Kim S., Housley R.M., Aukerman S.L., Tarpley J.E., Starnes C., Yin S., Pierce G.F., et al. Keratinocyte growth factor causes cystic dilation of the mammary glands of mice: Interactions of keratinocyte growth factor, estrogen, and progesterone in vivo. Am. J. Pathol. 145:1994a;1015-1022
320. Yi E.S., Yin S., Harclerode D.L., Bedoya A., Bikhazi N.B., Housley R.M., Aukerman S.L., Morris C.F., Pierce G.F., Ulich T.R. Keratinocyte growth factor induces pancreatic ductal epithelial proliferation. Am. J. Pathol. 145:1994b;80-85
321. Yi E.S., Shabaik A.S., Lacey D.L., Bedoya A.A., Yin S., Housley R.M., Danilenko D.M., Benson W., Cohen A.M., Pierce G.F., et al. Keratinocyte growth factor causes proliferation of urothelium in vivo. J. Urol. 154:1995;1566-1570
322. Yi E.S., Williams S.T., Lee H., Malicki D.M., Chin E.M., Yin S., Tarpley J., Ulich T.R. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am. J. Pathol. 149:1996;1963-1970
323. Yi E.S., Salgado M., Williams S., Kim S.J., Masliah E., Yin S., Ulich T.R. Keratinocyte growth factor decreases pulmonary edema, transforming growth factor-β and platelet-derived growth factor-BB expression, and alveolar type II cell loss in bleomycin-induced lung injury. Inflammation. 22:1998;315-325
324. Yusoff P., Lao D.H., Ong S.H., Wong E.S., Lim J., Lo T.L., Leong H.F., Fong C.W., Guy G.R. Sprouty2 inhibits the RasMAP kinase pathway by inhibiting the activation of Raf. J. Biol. Chem. 277:2002;3195-3201
325. Zeeh J.M., Procaccino F., Hoffmann P., Aukerman S.L., McRoberts J.A., Soltani S., Pierce G.F., Lakshmanan J., Lacey D., Eysselein V.E. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology. 110:1996;1077-1083
326. Zeigler M.E., Chi Y., Schmidt T., Varani J. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J. Cell. Physiol. 180:1999;271-284
327. Zhang J.D., Cousens L.S., Barr P.J., Sprang S.R. Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1β Proc. Natl. Acad. Sci. USA. 88:1991;3446-3450
328. Zhang Y., Sugimoto Y., Kulp S.K., Farrar W.B., Brueggemeier R.W., Lin Y.C. Estrogen-induced keratinocyte growth factor mRNA expression in normal and cancerous human breast cells. Oncol. Rep. 5:1998;577-583
329. Zhang Y., Wang H., Toratani S., Sato J.D., Kan M., McKeehan W.L., Okamoto T. Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Proc. Natl. Acad. Sci. USA. 98:2001;11336-11340
330. Zheng J., Siren V., Vaheri A. Keratinocyte growth factor enhances urokinase-type plasminogen activator activity in HPV16 DNA-immortalized human uterine exocervical epithelial cells. Eur J. Cell Biol. 69:1996;128-134
331. Zhou J., Finch P.W. Identification of a novel transcriptional regulatory element within the promoter region of the keratinocyte growth factor gene that mediates inducibility to cyclic AMP. Biochim. Biophys. Acta. 1446:1999;71-81
332. Zhu X., Komiya H., Chirino A., Faham S., Fox G.M., Arakawa T., Hsu B.T., Rees D.C. Three-dimensional structures of acidic and basic fibroblast growth factors. Science. 251:1991;90-93
333. Zimonjic D.B., Kelley M.J., Rubin J.S., Aaronson S.A., Popescu N.C. Fluorescence in situ hybridization analysis of keratinocyte growth factor gene amplification and dispersion in evolution of great apes and humans. Proc. Natl. Acad. Sci. USA. 94:1997;11461-11465